Screener
PPH vs BBH
VanEck Pharmaceutical ETF vs VanEck Biotech ETF
Key differences
- Over the last 3 years, PPH has delivered higher annualized returns.
Side-by-side comparison
| PPH | BBH | |
|---|---|---|
| Annual cost (TER) | 0.36% | 0.35% |
| Fund size (AUM) | $966M | $365M |
| Since | 2011 | 2011 |
| Dividend yield | 2.12% | 0.52% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +24.5% | +26.8% |
| CAGR 3Y | +12.6% | +5.9% |
| CAGR 5Y | +9.8% | +1.2% |
| Sharpe 3Y | 0.63 | 0.21 |
| Volatility 1Y | 17.07% | 18.82% |
| Max drawdown | -29.70% | -39.86% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PPH and BBH
Explore further